HK1187892A1 - Thioamide compound, and method for producing the compound,[(4r,6r)-6- aminoethyl-1,3-dioxane-4-yl]acetate derivative and atorvastatin [(4r6r)-6--13--4-] - Google Patents
Thioamide compound, and method for producing the compound,[(4r,6r)-6- aminoethyl-1,3-dioxane-4-yl]acetate derivative and atorvastatin [(4r6r)-6--13--4-]Info
- Publication number
- HK1187892A1 HK1187892A1 HK14100943.2A HK14100943A HK1187892A1 HK 1187892 A1 HK1187892 A1 HK 1187892A1 HK 14100943 A HK14100943 A HK 14100943A HK 1187892 A1 HK1187892 A1 HK 1187892A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- compound
- atorvastatin
- aminoethyl
- dioxane
- producing
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C327/00—Thiocarboxylic acids
- C07C327/38—Amides of thiocarboxylic acids
- C07C327/40—Amides of thiocarboxylic acids having carbon atoms of thiocarboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C327/42—Amides of thiocarboxylic acids having carbon atoms of thiocarboxamide groups bound to hydrogen atoms or to acyclic carbon atoms to hydrogen atoms or to carbon atoms of a saturated carbon skeleton
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B53/00—Asymmetric syntheses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D207/33—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D207/337—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic System
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
- C07F7/1804—Compounds having Si-O-C linkages
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2011035006A JP5705580B2 (ja) | 2011-02-21 | 2011-02-21 | チオアミド化合物、チオアミド化合物の製造方法、[(4r,6r)−6−アミノエチル−1,3−ジオキサン−4−イル]アセテート誘導体の製造方法、及びアトルバスタチンの製造方法 |
PCT/JP2012/053323 WO2012114926A1 (ja) | 2011-02-21 | 2012-02-14 | チオアミド化合物、チオアミド化合物の製造方法、[(4r,6r)-6-アミノエチル-1,3-ジオキサン-4-イル]アセテート誘導体の製造方法、及びアトルバスタチンの製造方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1187892A1 true HK1187892A1 (en) | 2014-04-17 |
Family
ID=46720708
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK14100943.2A HK1187892A1 (en) | 2011-02-21 | 2014-01-29 | Thioamide compound, and method for producing the compound,[(4r,6r)-6- aminoethyl-1,3-dioxane-4-yl]acetate derivative and atorvastatin [(4r6r)-6--13--4-] |
Country Status (7)
Country | Link |
---|---|
US (1) | US8785690B2 (xx) |
EP (1) | EP2679580B1 (xx) |
JP (1) | JP5705580B2 (xx) |
CN (1) | CN103384659B (xx) |
HK (1) | HK1187892A1 (xx) |
IL (1) | IL228027A (xx) |
WO (1) | WO2012114926A1 (xx) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5986872B2 (ja) * | 2012-10-05 | 2016-09-06 | 公益財団法人微生物化学研究会 | 化合物、該化合物の製造方法、アセテート誘導体の製造方法、及びアトルバスタチンの製造方法、並びに不斉配位子の回収方法 |
CN105503815A (zh) * | 2014-09-22 | 2016-04-20 | 兰州大学 | 一种立普妥合成中间体的制备方法 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FI94339C (fi) | 1989-07-21 | 1995-08-25 | Warner Lambert Co | Menetelmä farmaseuttisesti käyttökelpoisen /R-(R*,R*)/-2-(4-fluorifenyyli)- , -dihydroksi-5-(1-metyylietyyli)-3-fenyyli-4-/(fenyyliamino)karbonyyli/-1H-pyrroli-1-heptaanihapon ja sen farmaseuttisesti hyväksyttävien suolojen valmistamiseksi |
CN1127503C (zh) * | 2000-12-08 | 2003-11-12 | 中国科学院上海有机化学研究所 | (r)-2-[3-(2-n-邻苯二甲酰亚胺基乙基)-4,5-二氢-5-异噁唑基]-乙酸、合成及用途 |
CZ292221B6 (cs) * | 2001-06-29 | 2003-08-13 | Léčiva, A. S. | Způsob výroby (4R,6R) terc-butyl[6-(2-aminoethyl)-2,2-dimethyl[1,3]dioxan-4-yl]acetátu a meziproduktů pro jeho výrobu |
DE60336324D1 (de) | 2002-08-09 | 2011-04-21 | Codexis Inc | Enzymatische verfahren zur herstellung 4-substituierter 3-hydroxybuttersäure-derivate |
GB0317393D0 (en) * | 2003-07-25 | 2003-08-27 | Avecia Ltd | Process and compounds |
EP1893767A1 (en) * | 2005-06-16 | 2008-03-05 | Pfizer, Inc. | Process for producing atorvastatin, pharmaceutically acceptable salts thereof and intermediates thereof |
WO2007029216A1 (en) * | 2005-09-09 | 2007-03-15 | Pfizer Science And Technology Ireland Limited | Preparation of an atorvastatin intermediate |
US20090216029A1 (en) * | 2005-09-16 | 2009-08-27 | Yatendra Kumar | Process for the production of atorvastatin calcium in amorphous form |
WO2007034909A1 (ja) * | 2005-09-22 | 2007-03-29 | Kaneka Corporation | (3r,5r)-7-アミノ-3,5-ジヒドロキシヘプタン酸誘導体の製造法 |
CN101805279A (zh) * | 2010-01-22 | 2010-08-18 | 绍兴民生医药有限公司 | 阿托伐他汀钙的制备方法 |
-
2011
- 2011-02-21 JP JP2011035006A patent/JP5705580B2/ja not_active Expired - Fee Related
-
2012
- 2012-02-14 CN CN201280009635.7A patent/CN103384659B/zh not_active Expired - Fee Related
- 2012-02-14 EP EP12750077.5A patent/EP2679580B1/en not_active Not-in-force
- 2012-02-14 WO PCT/JP2012/053323 patent/WO2012114926A1/ja active Application Filing
-
2013
- 2013-08-19 IL IL228027A patent/IL228027A/en not_active IP Right Cessation
- 2013-08-20 US US13/971,186 patent/US8785690B2/en not_active Expired - Fee Related
-
2014
- 2014-01-29 HK HK14100943.2A patent/HK1187892A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
US20130338375A1 (en) | 2013-12-19 |
IL228027A0 (en) | 2013-09-30 |
WO2012114926A1 (ja) | 2012-08-30 |
EP2679580B1 (en) | 2017-08-09 |
JP2012171904A (ja) | 2012-09-10 |
CN103384659A (zh) | 2013-11-06 |
EP2679580A1 (en) | 2014-01-01 |
CN103384659B (zh) | 2015-11-25 |
EP2679580A4 (en) | 2015-09-09 |
IL228027A (en) | 2015-05-31 |
JP5705580B2 (ja) | 2015-04-22 |
US8785690B2 (en) | 2014-07-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2628400A4 (en) | Cigarette and method for manufacturing same | |
EP2679592A4 (en) | NEW HETEROCYCLIC COMPOUND, PROCESS FOR PRODUCING INTERMEDIATE PRODUCTS THEREOF AND USE THEREOF | |
EP2639234A4 (en) | 6.7-INSATURATED-7-CARBAMOYL-MORPHINANE DERIVATIVE AND PROCESS FOR PRODUCING THE SAME | |
EP2579284A4 (en) | Capacitor and process for producing same | |
EP2608230A4 (en) | Capacitor, and method and program for manufacturing same | |
EP3156413A4 (en) | Ganirelix precursor and method for preparing ganirelix acetate by using anirelix precursor | |
EP2692738A4 (en) | ESTER COMPOUND OF CELLULOSIC DERIVATIVE AND METHOD FOR PREPARING THE SAME | |
EP2674422A4 (en) | 3-HYDROXY-6H-BENZO [C] CHROMEN-6-ONE DERIVATIVE AND METHOD FOR PRODUCING THE SAME | |
EP2657223A4 (en) | METAL-SALEN COMPLEX COMPOUND AND PROCESS FOR PRODUCING THE SAME | |
EP2401278A4 (en) | IMPROVED PROCESS FOR THE PREPARATION OF A CARBAPENEM ANTIBIOTICS | |
PL2216455T3 (pl) | Element łączący dla drewnianej konstrukcji zespolonej, drewniana konstrukcja zespolona i sposób jej wytwarzania | |
EP2719695A4 (en) | AZOLE DERIVATIVE, PROCESS FOR PRODUCING AZOLE DERIVATIVE, AND INTERMEDIATE COMPOUND | |
EP2677047A4 (en) | Method for collection of ruthenium or ruthenium compound | |
IL248698A0 (en) | History of 1-h-pyrrolidine-4,2-dione and processes for their preparation | |
HK1219269A1 (zh) | 化合物及其生產方法,以及用於生產磷酸奧司他韋的方法 | |
PL3586632T3 (pl) | Pochodne 10H-benzo[g]pterydyno-2,4-dionu, sposób ich wytwarzania i ich zastosowanie | |
IL215128A0 (en) | Method for producing alcohol compound | |
EP2813501A4 (en) | PROCESS FOR PREPARING A 4-BENZYL-1-METHYL-6-OXABICYCLO [3,2,0] HEPTIDE SERIVATE | |
HK1187892A1 (en) | Thioamide compound, and method for producing the compound,[(4r,6r)-6- aminoethyl-1,3-dioxane-4-yl]acetate derivative and atorvastatin [(4r6r)-6--13--4-] | |
EP3095777B8 (en) | Linezolid intermediate and method for synthesizing linezolid | |
EP2719681A4 (en) | METHOD FOR PRODUCING A CYCLOPENTANONE COMPOUND AND INTERMEDIATE PRODUCT THEREOF | |
EP2543658A4 (en) | PROCESS FOR PRODUCING A-ACYLOXYCARBONYL COMPOUND AND NO-ACYLOXYCARBONYL COMPOUND | |
EP2454247A4 (en) | NOVEL TETRAHYDROPYRANYL COMPOUND AND PROCESS FOR PRODUCING THE TETRAHYDROPYRANYLE COMPOUND | |
HK1174031A1 (en) | Synthetic intermediate of oxazole compound and method for producing the same | |
PL2723742T3 (pl) | Pochodne 10H-benzo[g]pterydyno-2,4-dionu, sposób ich wytwarzania i zastosowanie |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20210218 |